Moxifloxacin EP Impurity E - Request Quote

Moxifloxacin EP Impurity E is chemically 1-Cyclopropyl-6-fluoro-8-hydroxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid compound with 2,2,2-trifluoroacetic acid (1:1) (as per EP) ; 1-Cyclopropyl-6-fluoro-8-hydroxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid compound with 2,2,2-trifluoroacetic acid (1:1) (as per USP). It is also known as Moxifloxacin O-Desmethyl Analog : 8-Hydroxy Moxifloxacin (USP) ; Moxifloxacin USP related compound E. Moxifloxacin EP Impurity E is supplied with detailed characterization data compliant with regulatory guideline. Moxifloxacin EP Impurity E can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Moxifloxacin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.